{"cdcTestId":"2013-0610","testcaseName":"Dose 2 to dose 3 PCV 13 interval 28-4 days","vaccineGroup":"PCV","evaluationTestType":"Interval: At Absolute Minimum","forecastTestType":"Recommended based on age","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2022-04-25T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2022-06-25T00:00:00","vaccineName":"PREVNAR 13","cvx":"133","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-09-25T00:00:00","vaccineName":"PREVNAR 13","cvx":"133","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"PREVNAR 13","cvx":"133","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"4","earliestDate":"2023-04-25T00:00:00","recommendedDate":"2023-04-25T00:00:00","pastDueDate":"2023-09-21T00:00:00"},"doses":[{"dateAdministered":"2022-06-25T00:00:00","vaccineName":"PREVNAR 13","cvx":"133","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-09-25T00:00:00","vaccineName":"PREVNAR 13","cvx":"133","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"PREVNAR 13","cvx":"133","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2020-05-29T07:40:11.358","generalDescription":"This test case describes when dose #2 to dose #3 of the Pnuemococcal 13 vaccine is administered at an interval of 28-4 days that dose #3 is considered to be valid.","changedInVersion":"1.0","reasonForChange":""}